select a format

Single User License
USD 1500 INR 96060
Site License
USD 3000 INR 192120
Corporate User License
USD 4500 INR 288180

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Synta Pharmaceuticals Corp.-Product Pipeline Review-2015

Synta Pharmaceuticals Corp.-Product Pipeline Review-2015


  • Products Id :- GMDHC07279CDB
  • |
  • Pages: 52
  • |
  • July 2015
  • |
  • |
  Request for Sample Report

Executive Summary

Synta Pharmaceuticals Corp.-Product Pipeline Review-2015

Summary

Global Markets Direct's, 'Synta Pharmaceuticals Corp.-Product Pipeline Review-2015', provides an overview of the Synta Pharmaceuticals Corp.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Synta Pharmaceuticals Corp.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides brief overview of Synta Pharmaceuticals Corp. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Synta Pharmaceuticals Corp.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Synta Pharmaceuticals Corp.'s pipeline products

Reasons To Buy

Evaluate Synta Pharmaceuticals Corp.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Synta Pharmaceuticals Corp. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Synta Pharmaceuticals Corp.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Synta Pharmaceuticals Corp. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Synta Pharmaceuticals Corp.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Synta Pharmaceuticals Corp. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Synta Pharmaceuticals Corp. Snapshot 5

Synta Pharmaceuticals Corp. Overview 5

Key Information 5

Key Facts 5

Synta Pharmaceuticals Corp.-Research and Development Overview 6

Key Therapeutic Areas 6

Synta Pharmaceuticals Corp.-Pipeline Review 10

Pipeline Products by Stage of Development 10

Pipeline Products-Monotherapy 11

Synta Pharmaceuticals Corp.-Pipeline Products Glance 12

Synta Pharmaceuticals Corp.-Late Stage Pipeline Products 12

Phase III Products/Combination Treatment Modalities 12

Synta Pharmaceuticals Corp.-Clinical Stage Pipeline Products 13

Phase II Products/Combination Treatment Modalities 13

Phase I Products/Combination Treatment Modalities 14

Synta Pharmaceuticals Corp.-Early Stage Pipeline Products 15

Preclinical Products/Combination Treatment Modalities 15

Discovery Products/Combination Treatment Modalities 16

Synta Pharmaceuticals Corp.-Drug Profiles 17

ganetespib 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

elesclomol 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

Small Molecule to Inhibit HSP90 for Inflammation 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

Small Molecules to Block CRACM Channel for Inflammation and Rheumatoid Arthritis 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

STA-128666 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

STA-129183 28

Product Description 28

Mechanism of Action 28

R&D Progress 28

STA-2842 29

Product Description 29

Mechanism of Action 29

R&D Progress 29

Small Molecule to Inhibit IL 12/IL 23 for Autoimmune Disorders and Inflammation 30

Product Description 30

Mechanism of Action 30

R&D Progress 30

Synta Pharmaceuticals Corp.-Pipeline Analysis 31

Synta Pharmaceuticals Corp.-Pipeline Products by Target 31

Synta Pharmaceuticals Corp.-Pipeline Products by Route of Administration 32

Synta Pharmaceuticals Corp.-Pipeline Products by Molecule Type 33

Synta Pharmaceuticals Corp.-Pipeline Products by Mechanism of Action 34

Synta Pharmaceuticals Corp.-Recent Pipeline Updates 35

Synta Pharmaceuticals Corp.-Dormant Projects 45

Synta Pharmaceuticals Corp.-Discontinued Pipeline Products 46

Discontinued Pipeline Product Profiles 46

apilimod mesylate 46

Synta Pharmaceuticals Corp.-Company Statement 47

Synta Pharmaceuticals Corp.-Locations And Subsidiaries 50

Head Office 50

Other Locations & Subsidiaries 50

Appendix 51

Methodology 51

Coverage 51

Secondary Research 51

Primary Research 51

Expert Panel Validation 51

Contact Us 51

Disclaimer 52

List of Tables

Synta Pharmaceuticals Corp., Key Information 5

Synta Pharmaceuticals Corp., Key Facts 5

Synta Pharmaceuticals Corp.-Pipeline by Indication, 2015 7

Synta Pharmaceuticals Corp.-Pipeline by Stage of Development, 2015 10

Synta Pharmaceuticals Corp.-Monotherapy Products in Pipeline, 2015 11

Synta Pharmaceuticals Corp.-Phase III, 2015 12

Synta Pharmaceuticals Corp.-Phase II, 2015 13

Synta Pharmaceuticals Corp.-Phase I, 2015 14

Synta Pharmaceuticals Corp.-Preclinical, 2015 15

Synta Pharmaceuticals Corp.-Discovery, 2015 16

Synta Pharmaceuticals Corp.-Pipeline by Target, 2015 31

Synta Pharmaceuticals Corp.-Pipeline by Route of Administration, 2015 32

Synta Pharmaceuticals Corp.-Pipeline by Molecule Type, 2015 33

Synta Pharmaceuticals Corp.-Pipeline Products by Mechanism of Action, 2015 34

Synta Pharmaceuticals Corp.-Recent Pipeline Updates, 2015 35

Synta Pharmaceuticals Corp.-Dormant Developmental Projects,2015 45

Synta Pharmaceuticals Corp.-Discontinued Pipeline Products, 2015 46

Synta Pharmaceuticals Corp., Other Locations 50

Synta Pharmaceuticals Corp., Subsidiaries 50

List of Figures

Synta Pharmaceuticals Corp.-Pipeline by Top 10 Indication, 2015 7

Synta Pharmaceuticals Corp.-Pipeline by Stage of Development, 2015 10

Synta Pharmaceuticals Corp.-Monotherapy Products in Pipeline, 2015 11

Synta Pharmaceuticals Corp.-Pipeline by Top 10 Target, 2015 31

Synta Pharmaceuticals Corp.-Pipeline by Top 10 Route of Administration, 2015 32

Synta Pharmaceuticals Corp.-Pipeline by Top 10 Molecule Type, 2015 33

Synta Pharmaceuticals Corp.-Pipeline Products by Top 10 Mechanism of Action, 2015 34

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Current R&D Portfolio of Synta Pharmaceuticals Corp.; Synta Pharmaceuticals Corp. - Key Therapeutics; Synta Pharmaceuticals Corp. - Pipeline Overview and Promising Molecules; Synta Pharmaceuticals Corp. - News; Synta Pharmaceuticals Corp. - Latest Updates; Synta Pharmaceuticals Corp. - Pipeline; Synta Pharmaceuticals Corp. - Discontinued/Dormant Projects


Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com